Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia.

IF 1
Gözde Akın Kağızmanlı, Özge Besci, Kübra Yüksek Acinikli, Gül Şeker, Elif Yaşar, Yeşim Öztürk, Korcan Demir, Ece Böber, Ayhan Abacı
{"title":"Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia.","authors":"Gözde Akın Kağızmanlı,&nbsp;Özge Besci,&nbsp;Kübra Yüksek Acinikli,&nbsp;Gül Şeker,&nbsp;Elif Yaşar,&nbsp;Yeşim Öztürk,&nbsp;Korcan Demir,&nbsp;Ece Böber,&nbsp;Ayhan Abacı","doi":"10.1515/jpem-2022-0368","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Large cell calcifying Sertoli cell tumours (LCCSCTs) are one of the infrequent causes of prepubertal gynaecomastia. Most of these tumours are in the content of Peutz-Jeghers syndrome (PJS) or other familial syndromes (Carney complex).</p><p><strong>Case presentation: </strong>Here, we report a long-term follow-up of an 8.5-year-old prepubertal boy with a diagnosis of PJS, who presented with bilateral gynaecomastia, advanced bone age and accelerated growth velocity, and were found to have bilateral multifocal testicular microcalcifications. As the findings were compatible with LCCSCT, anastrozole was initiated. Gynaecomastia completely regressed and growth velocity and pubertal development were appropriate for age during follow-up. Testicular lesions slightly increased in size. After four years of medication, anastrozole was discontinued but was restarted due to the recurrence of gynaecomastia after six months.</p><p><strong>Conclusions: </strong>Testicular tumour should be investigated in a patient with PJS who presents with prepubertal gynaecomastia. When findings are consistent with LCCSCT, aromatase inhibitors may be preferred in the treatment.</p>","PeriodicalId":520684,"journal":{"name":"Journal of pediatric endocrinology & metabolism : JPEM","volume":" ","pages":"1565-1570"},"PeriodicalIF":1.0000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pediatric endocrinology & metabolism : JPEM","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/jpem-2022-0368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/16 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Large cell calcifying Sertoli cell tumours (LCCSCTs) are one of the infrequent causes of prepubertal gynaecomastia. Most of these tumours are in the content of Peutz-Jeghers syndrome (PJS) or other familial syndromes (Carney complex).

Case presentation: Here, we report a long-term follow-up of an 8.5-year-old prepubertal boy with a diagnosis of PJS, who presented with bilateral gynaecomastia, advanced bone age and accelerated growth velocity, and were found to have bilateral multifocal testicular microcalcifications. As the findings were compatible with LCCSCT, anastrozole was initiated. Gynaecomastia completely regressed and growth velocity and pubertal development were appropriate for age during follow-up. Testicular lesions slightly increased in size. After four years of medication, anastrozole was discontinued but was restarted due to the recurrence of gynaecomastia after six months.

Conclusions: Testicular tumour should be investigated in a patient with PJS who presents with prepubertal gynaecomastia. When findings are consistent with LCCSCT, aromatase inhibitors may be preferred in the treatment.

芳香化酶抑制剂治疗1例大细胞钙化支持细胞肿瘤相关青春期前女性乳房发育的疗效。
目的:大细胞钙化支持细胞肿瘤(LCCSCTs)是青春期前女性乳房发育的罕见病因之一。这些肿瘤多数为Peutz-Jeghers综合征(PJS)或其他家族性综合征(Carney complex)。病例介绍:在这里,我们报告了一名8.5岁的青春期前男孩的长期随访,他被诊断为PJS,他表现为双侧妇科乳房发育,骨龄提前和生长速度加快,并发现双侧多灶性睾丸微钙化。由于结果与LCCSCT一致,因此开始使用阿那曲唑。随访期间,女性乳房发育完全消退,生长速度和青春期发育与年龄相符。睾丸病变体积略有增大。用药四年后,停用阿那曲唑,但由于6个月后复发的女性乳房发育症而重新开始。结论:出现青春期前女性乳房发育的PJS患者应考虑睾丸肿瘤。当结果与LCCSCT一致时,芳香化酶抑制剂可能是首选的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信